
Raymond James gives an Outperform recommendation for Apellis Pharmaceuticals Inc (APLS)
Apellis Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million
Apellis Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
In a filing, Apellis Pharmaceuticals Inc revealed its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
In a filing, Apellis Pharmaceuticals Inc revealed its Officer Francois Cedric acquired Company’s shares for reported $38168.0 on Jul 15
Apellis Pharmaceuticals Inc’s recently made public that its General Counsel Watson David O. unloaded Company’s shares for reported $93850.0 on
Apellis Pharmaceuticals Inc’s recently made public that its General Counsel Watson David O. unloaded Company’s shares for reported $93850.0 on